Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5–6 years after completion of the primary series

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 16, Issue 3, 2020
http://www.tandfonline.com/toc/khvi20/current

 

Article
Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5–6 years after completion of the primary series
Juliana Park, Sophia Archuleta, May-Lin Helen Oh, Lynette Pei-Chi Shek, Jing Jin, Matthew Bonaparte, Carina Fargo & Alain Bouckenooghe
Pages: 523-529
Published online: 05 Nov 2019